Copyright
©The Author(s) 2019.
World J Gastrointest Endosc. Feb 16, 2019; 11(2): 115-123
Published online Feb 16, 2019. doi: 10.4253/wjge.v11.i2.115
Published online Feb 16, 2019. doi: 10.4253/wjge.v11.i2.115
Ref. | Age (yr), Sex | TBSA (%) | GI Symptoms | Extent of GI involvement/Complications | Treatment | Outcome |
[21] | 71, F | 30 | GI bleed, D | (1) Ileus, Intraabdominal abscess, Jejunal perforation, Gastiric/colonic ulcer; (2) LA grade C esophagitis | (1) Steroid, IVIg; (2) Plasmapheresis; (3) Surgery | Survived (LOS-2 mo) |
[14] | 74, M | 40 | - | Intestinal perforation | Steroid, IVIg | Expired (after 31 d) |
[22] | 44, F | 0 | GI bleed | Gastric/rectal erosions | Steroid | Survived (LOS-31 d) |
[23] | 62, F | > 30 | AP, V | Intestinal infarction | Intestinal resection | Expired (after few days) |
[24] | 28, M | 90 | AD | Mesentric ischaemia | (1) IVIg; (2) Jejeunal-ileal resection | Survived (LOS-10 d) |
[25] | 56, F | 60 | D, Hypoalbumenia | Esophageal/duodenal/ileocolonic erosions | Steroid, IVIg, TPN | Survived |
[26] | 61, F | - | Odynophagia, GI bleed | Esophageal/recto-sigmoid ulcers | Steroid | Survived (LOS-1 mo) |
[27] | 23, M | - | AP,D, GI bleed | Colonic ulcers | Steroid, Probiotics | Survived (DOI-2 mo) |
[28] | 8, M | 40 | V, AD, D | Ileoileal intussusception | Surgery | Survived (LOS-15 d) |
[29] | 71, F | 95 | AD, D, GI bleed | Esophageal/gastric/sigmoid colonic erosions | IVIg | Expired (after 24 h) |
[30] | 30, F | 61 | D, GI bleed | Jejunal/colonic ulcers | Steroid, TPN, PE | Survived (DOI-5 mo) |
[31] | 52, F | > 30 | D, GI bleed | Ileocolonic stenosis | Ileo-cecal resection | Survived |
[32] | 17, M | 73 | D, GI bleed | (1) Microscopic duodenitis; (2) Ileocolonic ulcerations | Steroid, TPN, EN, Probiotics | Survived (DOI-6 mo) |
[33] | 62, M | 70 | Massive GI bleed | Confluent esophago-gastroduodenal ulceration | Steroids | Expired (after 21 d) |
[34] | 81, F | 40 | Jaundice | Mucosal erosions in upper GI tract | IVIg | Survived (LOS-14 d) |
[35] | 46, F | > 75 | D, GI bleed | Mucosal sloughs/ulcers (autopsy) | Steroids, Cyclophosphamide | Expired (LOS-9 mo) |
[36] | 48, F | 40 | D, malabsorption, protein-losing enteropathy | (1) Gastritis; (2) Multiple ileal strictures; (3) Multiple pseudodiverticular sacs; (4) Pseudomembranes formation | TPN, Ileal resection | Survived (LOS > 9 mo) |
[12] | 69, F | 37 | AP, GI bleed | (1) Sigmoid colon ulcers; (2) Perforations (sigmoid colon, cecum); (3) Ileal necrosis | Steroids, Ileal resection/ colectomy | Survived (LOS-5 mo) |
[11] | 4 cases (mean 42 (3F:1M) | Mean 37 | AP and GI bleed in all | (1) Duodenitis (2 cases); (2) Oesophagitis (1 case); (3) Procosigmoiditis (4 cases); (4) Jejunoileal involvement (1 case) | Ileal resection (1case) | Expired (3 cases), Survived (1 case) |
[37] | 41, F | > 70 | AP, D, GI bleed | (1) Gastroduodenitis; (2) Sigmoiditis | Steroid | Expired (after 15 d) |
[38] | 53, F | > 75 | AP, D | Small bowel ulcers | Steroid | Expired (after 17 d) |
[39] | 48, F | - | AP, D, GI bleed | Subacute intestinal obstruction | Steroid | Expired (after 8 hrs) |
Total reported cases | 25 |
Age (range) | 8-81 yr |
M:F (ratio) | 7:18 |
TBSA (%) | 0%-95% (all patients except one had > 30% of skin involvement) |
Time of appearance of GI symptoms | 0 wk-7 wk (usually within two weeks) after appearance of rash/mucosal lesions |
Chief symptoms | GI bleeding-17 (68%) Diarrhoea-13 (52%) Abdominal pain-10 (40%) Abdominal distension-3 (12%) Vomiting-2 (8%) |
Complications/ Extent of GI involvement | Luminal erosions/inflammation-15 (60%) Ulcer (Single or multiple)-9 (36%) [Large bowel (6). Small bowel (3), Esophageal (3), Gastric (2)] Perforation-3 (12%) (small bowel/colon) Strictures-2 (8%) (ileal/ileo-colonic) Mesentric ischaemia/ Intestinal infarction/ Ileoileal intussusceptions,/ Pseudodiverticular sacs/ Intraabdominal abscess,/ Pseudomembranes formation/ Subacute intestinal obstruction-One each Malabsorption/ Hypoalbumenia/ Protein-losing enteropathy- One each |
Treatment | Medical [Steroids (14), IVig (4), TPN (4), Probiotics (2), PP (1), PE (1), EN (1)] Surgery-8 (32%) |
Outcome | Survived- 14 (56%) [LOS (range)- 10 d -9 mo, DOI (range)-1-6 mo] Expired-11 (44%) |
- Citation: Jha AK, Suchismita A, Jha RK, Raj VK. Spectrum of gastrointestinal involvement in Stevens - Johnson syndrome. World J Gastrointest Endosc 2019; 11(2): 115-123
- URL: https://www.wjgnet.com/1948-5190/full/v11/i2/115.htm
- DOI: https://dx.doi.org/10.4253/wjge.v11.i2.115